EPS for MiMedx Group Inc (MDXG) Expected At $0.08

October 12, 2017 - By Nellie Frank

 EPS for MiMedx Group Inc (MDXG) Expected At $0.08
Investors sentiment increased to 2.02 in 2017 Q2. Its up 0.59, from 1.43 in 2017Q1. It improved, as 16 investors sold MiMedx Group Inc shares while 41 reduced holdings. 48 funds opened positions while 67 raised stakes. 66.99 million shares or 10.63% more from 60.55 million shares in 2017Q1 were reported.
Convergence Inv Ltd has invested 0.11% in MiMedx Group Inc (NASDAQ:MDXG). Raymond James Associate invested 0.01% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG). 1492 Capital Mngmt Limited Com stated it has 0.75% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG). 2,807 are owned by Fincl Bank Of Montreal Can. Stephens Invest Mngmt Group Incorporated Lc invested in 0.41% or 1.13 million shares. Geode Capital Mgmt Ltd Co accumulated 1.02M shares or 0.01% of the stock. Pinebridge Investments Ltd Partnership accumulated 13,438 shares. First Savings Bank stated it has 0.1% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG). Thompson Mngmt Incorporated, a Wisconsin-based fund reported 341,650 shares. Nordea Investment Mgmt stated it has 7,153 shares or 0% of all its holdings. Quantbot Technologies Lp stated it has 0.01% in MiMedx Group Inc (NASDAQ:MDXG). Mckinley Capital Lc Delaware owns 153,358 shares for 0.09% of their portfolio. Texas Permanent School Fund holds 74,472 shares. Wms Prtnrs Limited Liability holds 0.05% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG) for 25,259 shares. Bnp Paribas Arbitrage holds 30,561 shares.

Since May 25, 2017, it had 0 buys, and 2 insider sales for $1.53 million activity.

Analysts await MiMedx Group Inc (NASDAQ:MDXG) to report earnings on October, 26. They expect $0.08 earnings per share, up 166.67 % or $0.05 from last year’s $0.03 per share. MDXG’s profit will be $9.00 million for 41.41 P/E if the $0.08 EPS becomes a reality. After $0.07 actual earnings per share reported by MiMedx Group Inc for the previous quarter, Wall Street now forecasts 14.29 % EPS growth. About 3.42M shares traded or 1.18% up from the average. MiMedx Group Inc (NASDAQ:MDXG) has risen 107.87% since October 13, 2016 and is uptrending. It has outperformed by 91.17% the S&P500.

MiMedx Group Inc (NASDAQ:MDXG) Ratings Coverage

Among 8 analysts covering MiMedx Group (NASDAQ:MDXG), 6 have Buy rating, 2 Sell and 0 Hold. Therefore 75% are positive. MiMedx Group had 19 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Needham with “Buy” on Monday, June 26. As per Friday, July 14, the company rating was maintained by Needham. Needham maintained MiMedx Group Inc (NASDAQ:MDXG) on Tuesday, October 10 with “Buy” rating. The stock of MiMedx Group Inc (NASDAQ:MDXG) earned “Buy” rating by Needham on Wednesday, August 30. Needham downgraded MiMedx Group Inc (NASDAQ:MDXG) rating on Wednesday, July 29. Needham has “Buy” rating and $15 target. The stock has “Buy” rating by Piper Jaffray on Thursday, September 21. On Thursday, August 3 the stock rating was initiated by Needham with “Buy”. The stock has “Strong Buy” rating by Needham on Monday, November 16. First Analysis maintained the stock with “Overweight” rating in Wednesday, January 20 report. The company was downgraded on Tuesday, May 23 by First Analysis.

MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The company has market cap of $1.49 billion. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. It has a 71.47 P/E ratio. The Company’s biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix.

More important recent MiMedx Group Inc (NASDAQ:MDXG) news were published by: Zacks.com which released: “MiMedx Group (MDXG) Looks Good: Stock Adds 5.4% in Session October 11, 2017” on October 11, 2017, also Seekingalpha.com published article titled: “MiMedx: Undisclosed Details Undermine ‘Independent’ Investigation”, Seekingalpha.com published: “MiMedx: America’s 5th-Fastest-Growing Company” on October 02, 2017. More interesting news about MiMedx Group Inc (NASDAQ:MDXG) was released by: Streetinsider.com and their article: “MiMedx Group (MDXG) Prelim. Q3 Revenue Tops Views” with publication date: October 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: